Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer

Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer

Abstract The objective of this study was to determine the proportion of phase 3 clinical trials investigating a systemic therapy for patients with prostate, breast, lung, or colorectal cancer that excluded patients with Chronic Kidney Disease (CKD) and the exclusion criteria chosen, if any. A search...

Full description

Bibliographic Details
Main Authors: Matthieu Delaye, Adrien Rousseau, Mélanie Try, Christophe Massard, Luca Campedel, Marc Hilmi, Corinne Bagnis
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
chronic kidney disease
enrollment
onco‐nephrology
phase 3 trials
Online Access:https://doi.org/10.1002/cam4.5171

Similar Items

Similar Items